LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 11504 | 11155 | 1.0313 | 1.0369 |
MCF 10A | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 8365 | 11155 | 0.7498 | 0.7051 |
MCF 10A | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 10406 | 11155 | 0.9329 | 0.9208 |
MCF 10A | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 11019 | 11155 | 0.9878 | 0.9856 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 7909 | 11155 | 0.7090 | 0.6569 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1694 | 775 | 11155 | 0.0695 | -0.0971 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1694 | 630 | 11155 | 0.0565 | -0.1125 |
MCF 10A | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 10046 | 11155 | 0.9006 | 0.8828 |
MCF 10A | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2674 | 11155 | 0.2398 | 0.1036 |
MCF 10A | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 11124 | 11155 | 0.9972 | 0.9967 |
MCF 10A | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 9454 | 11155 | 0.8475 | 0.8202 |
MCF 10A | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 10125 | 11155 | 0.9077 | 0.8911 |
MCF 10A | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2934 | 11155 | 0.2630 | 0.1310 |
MCF 10A | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 4764 | 11155 | 0.4271 | 0.3245 |
MCF 10A | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 5616 | 11155 | 0.5035 | 0.4146 |
MCF 10A | PD0325901 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2566 | 11155 | 0.2301 | 0.0922 |
MCF 10A | PD0325901 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2257 | 11155 | 0.2024 | 0.0595 |
MCF 10A | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 10831 | 11155 | 0.9710 | 0.9658 |
MCF 10A | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 3347 | 11155 | 0.3000 | 0.1747 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2453 | 11155 | 0.2199 | 0.0802 |
MCF 10A | PF431396 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1880 | 11155 | 0.1685 | 0.0196 |
MCF 10A | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 4724 | 11155 | 0.4235 | 0.3202 |
MCF 10A | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2166 | 11155 | 0.1942 | 0.0499 |
MCF 10A | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 10469 | 11155 | 0.9385 | 0.9275 |
MCF 10A | PHA-793887 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 1580 | 11155 | 0.1416 | -0.0121 |